More on GELS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.04 |
|
|||
| Open | $1.03 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.09 | ||||
| Day Low | $1.00 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 101,218 | ||||
- Gelteq launches vet and human trials, secures $3.5M financing
- Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs
- Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications
- Gelteq opens China center to boost drug development operations
- Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
- Form 6-K Gelteq Ltd For: Jun 02
- Form 6-K Gelteq Ltd For: May 26
- Gelteq begins veterinary clinical trial for antiparasitic drug candidate
- Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
- Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA
Entities mentioned with GELS
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- F1 | View Related Stories »
- IPO | View Related Stories »
- The Benchmark Company | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
